Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
This volatility comparison pits the dividend aristocrats ETF against the SP500 to help you evaluate relative risk and inform allocation decisions.
20,441 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
NVIDIA and SK hynix announce a deeper partnership to secure high-bandwidth memory amid Jensen Huang's warning that th...
alanis morissette quickly sells a Bay Area estate for $9.6 million, signaling momentum in the luxury market. The sale...
Many altcoins under $1 could offer outsized gains, but they also carry significant risk. This guide provides a practi...
Jim Cramer cautions that AI stock surges can reverse sharply if earnings fail to accelerate, a warning that comes as ...
Private equity is moving from wall street legends to the everyday investor. Here’s how cathie wood's private equity i...
Merlin's chief technology officer argues that autonomous systems could redefine aviation safety and national security...
Analysts warn that social security faces insolvency by 2032, threatening to reduce guaranteed benefits for 70 million...
Marvell Technology’s shares push higher on AI-driven demand, approaching a 200% year-to-date gain. Yet a blinking red...
As mortgage rates stay stubbornly high, UWM Holdings shows resilience by growing market share through manufacturing e...
Bitcoin moved back above the $62,000 mark after a CPI release eased rate-hike fears, signaling a tentative relief ral...
Bitcoin is pulling back as demand metrics weaken, forcing traders to rethink near-term bets. Analysts warn a break be...